Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment
Open Access
- 25 May 2022
- journal article
- research article
- Published by Elsevier in Continence
- Vol. 2
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30 DK079307, R01 AG056944, R01 HL 109002)
This publication has 25 references indexed in Scilit:
- Vasopressin Receptors in Voiding Dysfunction2011
- Desmopressin is an Effective Treatment for Mixed Nocturia with Nocturnal Polyuria and Decreased Nocturnal Bladder CapacityJournal of Korean Medical Science, 2010
- ATP and adenosine in the local regulation of water transport and homeostasis by the kidneyAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Urinary Bladder Contraction and Relaxation: Physiology and PathophysiologyPhysiological Reviews, 2004
- Modulation by desmopressin of neuronal activity in brainstem micturition centerUrology, 2004
- V2-receptor–mediated relaxation of human renal arteries in response to desmopressinAmerican Journal of Hypertension, 1999
- Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Phosphorylation of the V2 Vasopressin ReceptorJournal of Biological Chemistry, 1997
- Content and contractile effect of arginine vasopressin in rat urinary bladderEuropean Journal of Pharmacology, 1990
- Urinary and metabolic clearances of arginine vasopressin in normal subjectsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1986